PPARgamma and the thiazolidinediones: molecular basis for a treatment of 'Syndrome X'?

Diabetes Obes Metab. 2002 Jul;4(4):239-48. doi: 10.1046/j.1463-1326.2002.00187.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Insulin Resistance / physiology*
  • Metabolic Syndrome / drug therapy*
  • Microbodies / physiology
  • Receptors, Cytoplasmic and Nuclear / physiology*
  • Thiazoles / therapeutic use*
  • Transcription Factors / physiology*

Substances

  • Receptors, Cytoplasmic and Nuclear
  • Thiazoles
  • Transcription Factors